Literature DB >> 12690925

Efficacy of high-dose intravenous immunoglobulins in two patients with idiopathic recurrent pericarditis refractory to previous immunosuppressive treatment.

Francesco Tona1, Fabio Bellotto, Francesco Laveder, Alessia Meneghin, Gianfranco Sinagra, Renzo Marcolongo.   

Abstract

Although idiopathic acute pericarditis is usually a self-limiting disease, in many patients it may recur over a period of months or years. Even if some evidence seems to suggest the possible role of a deranged immune reactivity in the pathogenesis of idiopathic recurrent pericarditis, the etiology of the disease is still unknown. Furthermore, while some trial data confirm the usefulness of colchicine, its medical treatment is not yet clearly established. We here report the clinical history of 2 patients with idiopathic recurrent pericarditis resistant to prednisone, colchicine and other immunosuppressive drugs, who have been successfully treated with high-dose intravenous immunoglobulins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12690925

Source DB:  PubMed          Journal:  Ital Heart J        ISSN: 1129-471X


  3 in total

1.  High-dose intravenous immunoglobulin in recurrent postpericardiotomy syndrome.

Authors:  G Wendelin; A Fandl; A Beitzke
Journal:  Pediatr Cardiol       Date:  2008-03       Impact factor: 1.655

2.  A case series and systematic literature review of anakinra and immunosuppression in idiopathic recurrent pericarditis.

Authors:  Ian C Scott; Vijay Hajela; Philip N Hawkins; Helen J Lachmann
Journal:  J Cardiol Cases       Date:  2011-08-12

3.  Efficacy of intravenous immunoglobulin in chronic idiopathic pericarditis: report of four cases.

Authors:  D Peterlana; A Puccetti; S Simeoni; E Tinazzi; R Corrocher; C Lunardi
Journal:  Clin Rheumatol       Date:  2004-07-14       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.